DEA and HHS extend virtual prescribing for controlled substances through 2025

DEA and HHS extend virtual prescribing for controlled substances through 2025

The third extension of pandemic-era telehealth flexibilities through the end of next year will give the agencies time to promulgate final regulations and providers time to comply, the agencies said.  News from healthcareitnews.com

​The third extension of pandemic-era telehealth flexibilities through the end of next year will give the agencies time to promulgate final regulations and providers time to comply, the agencies said. 

Leave a Reply

Your email address will not be published. Required fields are marked *